跳至主要内容
临床试验/NCT05277129
NCT05277129招募中不适用

The Immune Response to Stroke

University of Oslo1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
The B cell and T cell response in peripheral blood

研究概览

简要总结

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stroke < 72 h
  • Age > 18 years

排除标准

  • Brain hemorrhage verified by CT or MRI scan
  • Previous or present immunological disease or other serious comorbidity
  • Ongoing immune respons after infection or vaccination < 1 month
  • Cognitive without ability to understand and/or give an informed consent to participate in the study

结局指标

主要结局

The B cell and T cell response in peripheral blood

时间窗: 1 day (subject inclusion)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Lossius

Associate Professor

University of Oslo

研究点 (1)

Loading locations...

相似试验